Public Reporting

ACO Name and Location

TP-ACO L.L.C              

8702-A Jefferson Hwy

Baton Rouge, LA  70809

ACO Primary Contact

  Mr. John Woods

  844-252-5321

  Jwoods@TPACsecure.com

Organizational Information

ACO Participants:

ACO ParticipantsACO Participant in Joint Venture
AKWASI SEFAN
AMERICA’S FAMILY DOCTORS, PLLCN
BATON ROUGE GENERAL PHYSICIANS MEDICAL GROUP LLCN
Bethesda Rehabilitation Hospital, IncN
BUFFALO MEDICAL CENTER INCN
CHARLES A. GARCIA,MDPAN
CHARLES WOLOHONN
CHRISTINE L. MILLS SMITH, MD, LLCN
Community Quick Care of Lavergne PCN
COOL SPRINGS INTERNAL MEDICINE & PEDIATRICS, PLLC.N
COOL SPRINGS SURGICAL ASSOCIATES LLCN
DANNY D. CHENG M.D., P.A.N
DAVID OURSN
DHAR FAMILY MEDICINE, PLLCN
ELBERT A FASNACHT II MD LTDN
Eric EgliN
Family Care of Middle TennesseeN
FAMILY FIRST MEDICAL CLINICN
FAMILY HEALTH ASSOCIATESN
Family Medicine Associates of Blytheville, P.A.N
FAMILY PRACTICE PARTNERS, PCN
GARY SCHWARTZN
Gateway Healthcare PCN
GENESYS FAMILY MEDICINE, PCN
GEORGE HOPKINSN
Good Health Associates, PLLCN
HILLSBOROUGH MEDICAL ASSOCIATES LLCN
Internal Medicine Associates LLCN
J CHRIS BECKMAN MD PLLCN
JAMES W GARNER JR MD PCN
Jared C BramlettN
JOHN BYRNESN
KEVIN L. KLEIN, DO PAN
KIRAN G ZAVERI MD LLCN
Logan Family Medicine, LLCN
MARK B. BLICK D.O., P.A.N
MAYO HEALTH SYSTEMS INCN
MCCOLLUM HOMETOWN HEALTHCARE PLLCN
MED EQUITY PARTNERS LLCN
Middle Tennessee Plastic Surgery, P.C.N
Middle Tennessee Urology Specialists P.L.L.C.N
MIDTNGYN PLLCN
Northfield Family Practice PCN
OPEN WATER MEDICAL PAN
PETER CHANGN
PETER DICORLETON
PRIMARY CARE CLINIC LLCN
PULMONARY & SLEEP OF TAMPA BAY PLN
RENE E DARVEAUX MD PAN
RICHARD SCHOCKN
ROSEMAY T LATORTUE MD PAN
STAN J MAYS MD A PROFESSIONAL MEDICAL CORPORATIONN
Sulkowski Family Medicine PLLCN
SUNSET POINT MEDICAL ASSOCIATES INCN
TENNESSEE HEALTHCARE PARTNERS, LLCN
TENNESSEE MEDICINE & PEDIATRICS, PCN
TERESA HUGGINSN
Thomas P. Melancon MD, LLCN
Wayne MurphyN

ACO Governing Body:

Member Last NameMember First NameMember Title/PositionMember’s Voting Power (Expressed as a percentage or number)Membership TypeACO Participant Legal Business Name and D/B/A, if applicable
CranorKennethMD/Chairman1ACO Participant RepresentativeThe Physicians Alliance Corporation
MarinoFredVoting Member1Medicare Beneficiary RepresentativeN/A
BatieDonnieMD/Voting Member1ACO Participant RepresentativeBaton Rouge General Physician’s Medical Group, LLC
SwarrPeterMD/Voting Member1ACO Participant RepresentativeCool Springs Internal Medicine and Pediatrics, PLLC
CarterDennisMD/Voting Member1ACO Participant RepresentativeFamily Health Associates
LatortueRosemayMD/Voting Member1ACO Participant RepresentativeRosemay T. LaTortue, MD., P.A.
MurphyWayneMD/Voting Member1ACO Participant RepresentativeWayne Murphy
PerkinsMattMD/Voting Member1ACO Participant RepresentativeTennessee Medicine and Pediatrics, PC
BlickMarkMD/Voting Member1ACO Participant RepresentativeMark B. Blick D.O., P.A.
WillisKerryMD/Voting Member1ACO Participant RepresentativeOpen Water Medical PA
ZaveriKiranMD/Voting Member1ACO Participant RepresentativeKiran G. Zaveri, MD LLC

Key ACO Clinical and Administrative Leadership:

ACO Executive: John Woods

Medical Director: Kirin Zaveri

Compliance Officer: John Woods

Quality Assurance/Improvement Officer: Kenneth Cranor

Associated Committees and Committee Leadership:

Committee NameCommittee Leader Name and Position
TP-ACO Patient Care CommitteeWarren McPherson, Chairman
Stones River Patient Care CommitteeDennis Carter, Chairman
Harpeth Patient Care CommitteePeter Swarr, Chairman

Types of ACO Participants, or Combinations of Participants, That Formed the ACO:

  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses:

Amount of Shared Savings/Losses:

  • Third Agreement Period
    • Performance Year 2020, $8,025,380
    • Performance Year 2019/2019A, $10,686,872
  • Second Agreement Period
    • Performance Year 2018, $5,712,042
    • Performance Year 2017, $3,292,526
    • Performance Year 2016, $2,459,316
  • First Agreement Period
    • Performance Year 2015, $1,662,988
    • Performance Year 2014, $3,133,900
    • Performance Year 2013, $4,721,981

Shared Savings Distribution:

  • Third Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: 15%
      • Proportion invested in redesigned care processes/resources: 28%
      • Proportion of distribution to ACO participants: 57%
    • Performance Year 2019/2019A
      • Proportion invested in infrastructure: 15%
      • Proportion invested in redesigned care processes/resources: 25%
      • Proportion of distribtuion to ACO participants: 60%
  • Second Agreement Period
    • Performance Year 2018
      • Proportion invested in infrastructure: 15%
      • Proportion invested in redesigned care processes/resources: 23%
      • Proportion of distribution to ACO participants: 62%
    • Performance Year 2017
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 5%
      • Proportion of distribution to ACO participants: 85%
      • Performance Year 2016
    • Performance Year 2016
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 5%
      • Proportion of distribution to ACO participants: 85%
  • First Agreement Period
    • Performance Year 2015
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 5%
      • Proportion of distribution to ACO participants: 85%
    • Performance Year 2014
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 5%
      • Proportion of distribution to ACO participants: 85%
    • Performance Year 2013
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 5%
      • Proportion of distribution to ACO participants: 85%

“Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.”

Quality Performance Results

2020 Quality Performance Results:

ACO Quality Measure NumberMeasure NameRateACO Mean
ACO-43Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))1.090.95
ACO-13Falls: Screening for Future Fall Risk93.9884.97
ACO-14Preventive Care and Screening: Influenza Immunization77.8876.03
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention95.4581.67
ACO-18Preventive Care and Screening: Screening for Depression and Follow-up Plan89.7471.46
ACO-19Colorectal Cancer Screening75.8172.59
ACO-20Breast Cancer Screening81.6874.05
ACO-42Statin Therapy for the Prevention and Treatment of Cardiovascular Disease86.4283.37
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control11.2414.70
ACO-28Hypertension (HTN): Controlling High Blood Pressure81.7572.87

“Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.”

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
    • No, our ACO does not use the SNF 3-Day Rule Waiver.
  • Waiver for Payment for Telehealth Services:
    • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.
  • Waiver to Coordinate Laboratory Services
    • As part of its efforts of advancing the Triple aim of i) improved patient outcomes and satisfaction, ii) promote better health for populations, and iii) lowering the per capita cost of care, our ACO has contracted with LabCorp to assist in the implementation and on-going operation of care coordination in general, and especially for the treatment and prevention chronic kidney disease.  This care coordination support will help ACO facilitate its efforts to implement case management and care coordination (76 Fed. Reg. at 68000 and 68002).